Dr. Martens plc (LON:DOCS - Get Free Report) was up 18% during trading on Thursday . The company traded as high as GBX 74.30 ($1.01) and last traded at GBX 70.75 ($0.96). Approximately 6,163,005 shares were traded during trading, an increase of 176% from the average daily volume of 2,233,193 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reduced their price target on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.
Get Our Latest Stock Report on DOCS
Dr. Martens Trading Up 25.8%
The stock has a market cap of £731.96 million, a P/E ratio of 10.69, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The stock's fifty day moving average is GBX 54.24 and its 200 day moving average is GBX 62.52.
Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities research analysts predict that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.
Dr. Martens Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. This represents a yield of 1.47%. The ex-dividend date was Thursday, March 6th. Dr. Martens's payout ratio is 42.53%.
Insider Buying and Selling at Dr. Martens
In other Dr. Martens news, insider Giles Wilson acquired 32,640 shares of the business's stock in a transaction on Tuesday, March 25th. The shares were bought at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,934.82). Insiders have bought 33,206 shares of company stock worth $1,792,771 over the last quarter. Insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
